Old Web
English
Sign In
Acemap
>
authorDetail
>
N. Kumarakulasinghe
N. Kumarakulasinghe
Medicine
Oncology
Internal medicine
Pathology
General surgery
4
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P2.13-27 Development, Internal Validation, and Calibration of a Risk Score to Predict Survival in Patients with EGFR Mutant NSCLC
2018
Journal of Thoracic Oncology
I. Ng
N. Kumarakulasinghe
N. Syn
Ross A. Soo
Show All
Source
Cite
Save
Citations (0)
P1.01-38 A Phase II With a Lead-In Phase I Study to Examine Safety and Efficacy of Hydroxychloroquine and Gefitinib in Advanced NSCLC
2018
Journal of Thoracic Oncology
Yiqing Huang
Alvin S. Wong
Ross A. Soo
T. Soh
Angela Pang
Chee Seng Tan
W. Ling
P.J. Voon
Joline Si Jing Lim
R. Sundar
N. Kumarakulasinghe
H.L. Lim
Boon Cher Goh
T. M. Chin
Show All
Source
Cite
Save
Citations (0)
P3.01-022 Prognostic Value of Clinical, Immune and Biochemical Markers in EGFR-Mutant NSCLC Patients Treated with First-Line EGFR TKIs
2017
Journal of Thoracic Oncology
I. Ng
N. Kumarakulasinghe
N. Syn
R. Teng
Ross A. Soo
Show All
Source
Cite
Save
Citations (0)
Validation of the Lung Cancer Specific Graded Prognostic Assessment (GPA) Model for Patients With EGFR Tested Non-Small Cell Lung Cancer With Brain Metastases
2015
International Journal of Radiation Oncology Biology Physics
Yu Yang Soon
Huili Zheng
N. Kumarakulasinghe
Brendan Pang
E.Y. Loy
W.Y. Koh
C.N. Leong
A.B. Asmat
Ross A. Soo
I Tham
Show All
Source
Cite
Save
Citations (0)
1